Jan 20, 2014, 01.26 PM IST
Unichem Labs logged a 12.4 percent growth in secondary sales-- made by distributors to chemists-during the December quarter when the industry grew at 5 percent, said Rakesh Parikh, VP Finance.
Tags Unichem Labs, earnings, profit, revenue, sales, international business, Unichem Laboratories
Like this story, share it with millions of investors on M3
Secondary sales growing above industry average: Unichem
Unichem Labs logged a 12.4 percent growth in secondary sales-- made by distributors to chemists-during the December quarter when the industry grew at 5 percent, said Rakesh Parikh, VP Finance.
Like this story, share it with millions of investors on M3
Secondary sales growing above industry average: Unichem
Unichem Labs logged a 12.4 percent growth in secondary sales-- made by distributors to chemists-during the December quarter when the industry grew at 5 percent, said Rakesh Parikh, VP Finance.
The company's US business has grown 35 percent during the nine months ended December and Parikh said the international business was witnessing some improvement.
Parikh expects the company to maintain a positive performance for at least two years.
Press release: Unichem Labs posts third-quarter earnings
December quarter net profit for the drugmaker stood at Rs 32 crore versus Rs 36.21 crore in the September quarter and Rs 30.3 crore in the year-ago quarter. Quarterly revenues stood at Rs 265 crore, versus Rs 266.19 crore in the previous quarter and Rs 231 crore year-on-year.
The company's net profit was boosted by an exceptional income from sale of SEZ land to Myland, Parikh said.
Talking about the impact of the new drug pricing policy, under which the government has put selected drugs under a fixed price regime, he said it could shave 2.5 percent off the firm's revenues. "The impact is expected to be resolved over the next few quarters."
He said new launches would add to the company's growth in the coming quarters.
Updates soon.
Unichem Labs stock price
On January 20, 2014, at 14:10 hrs Unichem Laboratories was quoting at Rs 216.20, down Rs 0.05, or 0.02 percent. The 52-week high of the share was Rs 225.45 and the 52-week low was Rs 138.00.
The company's trailing 12-month (TTM) EPS was at Rs 14.75 per share as per the quarter ended September 2013. The stock's price-to-earnings (P/E) ratio was 14.66. The latest book value of the company is Rs 89.73 per share. At current value, the price-to-book value of the company is 2.41.
Anda sedang membaca artikel tentang
Secondary sales growing above industry average: Unichem
Dengan url
https://kesehatanda.blogspot.com/2014/01/secondary-sales-growing-above-industry.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Secondary sales growing above industry average: Unichem
namun jangan lupa untuk meletakkan link
Secondary sales growing above industry average: Unichem
sebagai sumbernya
0 komentar:
Posting Komentar